U.S. Markets closed

How Alexion Pharmaceuticals Is Positioned in October

Kenneth Smith
How Alexion Pharmaceuticals Is Positioned in October

Alexion Pharmaceuticals (ALXN) is a leader in complement inhibition. It focuses on hematology, nephrology, neurology, and metabolic disorders. In this series, we’ll explore its financials, valuation metrics, latest developments, and analyst recommendations.